Improving In Vitro Models to Better Recapitulate Human Biology of Neurodegeneration
Time: 9:10 am
day: Conference Day Two
Details:
- Covering limitations, pros and cons, of in vivo and in vitro models for drug discovery in neurodegeneration
- Development of in vitro iPSC models for AD drug discovery. Evaluation of donor differences by RNA-seq.
- Roadmap to scaling up production of iPSC-microglia and neurons using automation
